Can we provide point-of-care viral load tests in poor countries?
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors
WHO recommends global use of newest hepatitis C drugs, urges price reductions
Giving treatment to specific high-risk people may bring down HIV faster than distributing it equally
Risk score can help predict which people living with HIV have highest risk of kidney disease during tenofovir treatment
Women with circumcised partners less likely to have HIV, no less likely to use condoms
Rare case of lesbian transmission of HIV reported in US
Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds
Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation
